| Improved survival with integration of Chinese herbal medicine therapy in patients with acute myeloid leukemia: a nationwide population-based cohort study T Fleischer, TT Chang, JH Chiang, MF Sun, HR Yen Integrative cancer therapies 16 (2), 156-164, 2017 | 47 | 2017 |
| Adjunctive Chinese herbal medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population‐based cohort study T Fleischer, TT Chang, JH Chiang, CM Chang, CY Hsieh, HR Yen Cancer Medicine 5 (4), 640-648, 2016 | 33 | 2016 |
| Integration of Chinese herbal medicine therapy improves survival of patients with chronic lymphocytic leukemia: a nationwide population-based cohort study T Fleischer, TT Chang, JH Chiang, CY Hsieh, MF Sun, HR Yen Medicine 95 (21), e3788, 2016 | 26 | 2016 |
| How do government regulations influence the ability to practice Chinese herbal medicine in western countries T Fleischer, YC Su, SJS Lin Journal of ethnopharmacology 196, 104-109, 2017 | 22 | 2017 |
| Post-hematopoietic stem cell transplantation in patients with hematologic disorders: Chinese herbal medicine for an unmet need T Fleischer, TT Chang, HR Yen Journal of Integrative Medicine 14 (5), 322-335, 2016 | 15 | 2016 |
| A controlled trial of Sheng-Yu-Tang for post–hematopoietic stem cell transplantation leukemia patients: a proposed protocol and insights from a preliminary pilot study T Fleischer, TT Chang, JH Chiang, HR Yen Integrative Cancer Therapies 17 (3), 665-673, 2018 | 5 | 2018 |
| Targeting SRSF2 mutations in leukemia with RKI-1447: A strategy to impair cellular division and nuclear structure M Su, T Fleischer, I Grosheva, MB Horev, M Olszewska, CC Mattioli, ... Iscience 27 (4), 2024 | | 2024 |
| Method of treating myeloid malignancies L Shlush, T Fleischer, B Geiger, M Su US Patent App. 18/134,064, 2023 | | 2023 |
